top of page

​*denotes equal contribution

  • Jia D*, George JT*, Tripathi SC, Kundnani D, Lu M, Hanash SM, Onuchic JN, Jolly MK, Levine H (2019). Testing the gene expression classification of the EMT spectrum. Physical Biology, 16 (2): 025002

  • George JT*, Jolly MK*, Xu S, Somarelli JA, Levine H (2017). Survival outcome in cancer patients predicted by a partial EMT gene expression scoring metric. Cancer Research, 77 (22): 6415-6428

  • Somarelli JA, Shelter S, Jolly MK, Wang S, Bartholf-Dewitt S, Hish A, Gilja S, Eward W, Ware K, Levine H, Armstrong AJ, Garcia-Blanco MA (2016). Mesenchymal-epithelial transition in sarcomas is controlled by the combinatorial expression of GRHL2 and miR-200s. Molecular and Cellular Biology, 36 (19): 2503-2513 (Cover article)

  • Jolly MK, Tripathi SC, Jia D, Mooney SM, Celiktas M, Mani SA, Hanash S, Pienta KJ, Ben-Jacob E, Levine H (2016). Stability of the hybrid epithelial /mesenchymal phenotype. Oncotarget, 7 (19): 27067-27084

  • Jolly MK*, Jia D*, Boareto M, Mani SA, Pienta KJ, Ben-Jacob E, Levine H (2015). Coupling the modules of EMT and stemness: A tunable 'stemness window' model. Oncotarget, 6(28): 25161-25174

  • Jolly MK, Boareto M, Huang B, Jia D, Lu M, Onuchic JN, Ben-Jacob E, Levine H (2015). Implications of the hybrid epithelial/mesenchymal phenotype in metastasis.  Frontiers in Oncology,5: 155

bottom of page